Sigyn Therapeutics, Inc.
SIGY
$2.75
$0.2610.44%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 11.81% | 55.55% | -32.15% | -19.26% | 43.47% |
| Total Depreciation and Amortization | -6.67% | -62.16% | 1,500.00% | -46.15% | -42.31% |
| Total Amortization of Deferred Charges | -3.55% | -81.45% | 35.93% | -27.49% | -84.83% |
| Total Other Non-Cash Items | 33.33% | -13.91% | 738.11% | 121.92% | 72.81% |
| Change in Net Operating Assets | -43.75% | -69.18% | 56.90% | 85.56% | 544.33% |
| Cash from Operations | -24.96% | -126.90% | 55.00% | 44.39% | 58.12% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 6.65% | 141.33% | -25.56% | 662.00% | -68.62% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 14.95% | 83.47% | -32.10% | 578.67% | -70.70% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -96.21% | -188.47% | 170.98% | 106.96% | -93.28% |